Adimab's Collaborator GSK Celebrates New Approvals for Depemokimab in Europe and China #United_States #GSK #Lebanon #Adimab #Depemokimab
0
0
0
0
Adimab's Collaborator GSK Celebrates New Approvals for Depemokimab in Europe and China #United_States #GSK #Lebanon #Adimab #Depemokimab
Adimab Achieves Significant Growth in Clinical Programs for 2025 #USA #Clinical_Trials #Lebanon,_NH #Antibody_Discovery #Adimab
Adimab Sees Record Growth in Partnerships and New Programs for 2025 #None #partnerships #Therapeutic_Antibodies #Adimab